Zyprexa

Grasso has over 10 years of experience in biopharmaceutical R&D.

He co-founded Morphotek and has served as its VP of Research since its inception.

His team's efforts have led to the development of a pipeline of therapeutic antibodies in the area of cancer, inflammation and infectious disease.

He received his Ph.D.

in Pathology from the University of Catania, Italy and has held various R&D positions within the biopharmaceutical industry.

He has authored several papers in leading peer review journals and is an inventor with several key patents involving Morphotek's technologies and products."I am pleased to announce the addition of Bob to the team and the well deserved promotion of Luigi to Sr.

Vice President," commented Nicholas C.

Nicolaides, Ph.D., President and Chief Executive Officer of Morphotek.

"Bob brings a breadth of knowledge, energy and leadership to the company that will facilitate development of our technology and products for value creation.

His keen understanding of product development and pharmaceutical sales will undoubtedly help the company execute its goals in establishing alliances with appropriate partners who are capable of helping us advance our compounds from the clinic to the market as well as sign additional technology alliances.

Luigi's leadership in R&D has been essential for helping the company to optimize, validate and implement its technologies fr...

Read more...